Tag: NSCLC
-
Genomic Testing for NSCLC: Insights from the AONN+ Conference for Oncology Navigators
Understanding genomic testing in NSCLC Genomic testing for non-small cell lung cancer (NSCLC) has evolved from a optional add-on to a cornerstone of personalized care. At the recent AONN+ conference, a focused session explored how oncology nurses, advanced practitioners, and navigators can effectively use biomarker testing to inform treatment decisions across NSCLC subtypes. The goal…
-
Genomic Testing for NSCLC: Session Highlights for Oncology Navigators
Overview: Why Genomic Testing Matters in NSCLC Genomic testing has become a cornerstone of precision care for non-small cell lung cancer (NSCLC). During a recent session at the AONN+ Conference, experts highlighted how oncology nurses, advanced practitioners, and navigators can use biomarker information to guide testing and treatment decisions. For patients with different NSCLC subtypes,…
-
Genomic Testing for NSCLC: Session at AONN+ Conference Delivers Insights for Oncology Navigators
Overview: Why Genomic Testing in NSCLC Matters for Navigators Genomic testing has become a cornerstone of non-small cell lung cancer (NSCLC) management. At the AONN+ conference, a dedicated session offered practical insights for oncology nurses, advanced practitioners, and navigators who guide patients through complex diagnostic and treatment pathways. The session emphasized that understanding which biomarker…
-
Google Maps for Lung Cancer: A New AI-Driven Path to Precision Treatment
Revolutionizing Lung Cancer Treatment with a Google Maps Approach Researchers are adopting a groundbreaking method likened to a “Google maps” of cancer to guide treatment decisions for non-small cell lung cancer (NSCLC). In a multi-institution study led by Associate Professor Arutha Kulasinghe from the Frazer Institute at the University of Queensland, alongside teams at Yale…
-
Google-style Maps for NSCLC: AI-Driven Precision Lung Cancer Treatment
A New Era in Lung Cancer Treatment Researchers from the University of Queensland’s Frazer Institute and Yale University have unveiled a groundbreaking approach to treating non-small cell lung cancer (NSCLC). By combining artificial intelligence with spatial biology, the team analyzed tumors from 234 NSCLC patients across three cohorts in Australia, the United States, and Europe.…
-
New Google maps approach could revolutionise lung cancer treatment
A new map of lung cancer biology Researchers are proposing a “Google maps” style approach to cancer treatment, using artificial intelligence and spatial biology to chart non-small cell lung cancer (NSCLC) at a cell-by-cell level. In a study spanning 234 NSCLC patients across Australia, the United States and Europe, Associate Professor Arutha Kulasinghe from the…
-
Large Language Models in Lung Cancer: A Comprehensive Systematic Review
Introduction: The Rise of LLMs in Lung Cancer Care Large language models (LLMs) are increasingly explored as tools to assist in the full cycle of lung cancer (LC) management, from prevention and screening to diagnosis, treatment planning, and supportive care. This systematic review synthesizes recent evidence on how LLMs are being applied to LC, what…